MedPath
HSA Approval

IRINO Solution for I.V Infusion 20mg/ml

SIN14373P

IRINO Solution for I.V Infusion 20mg/ml

IRINO Solution for I.V Infusion 20mg/ml

June 21, 2013

PHARM-D SINGAPORE PRIVATE LIMITED

PHARM-D SINGAPORE PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARM-D SINGAPORE PRIVATE LIMITED
Licence HolderPHARM-D SINGAPORE PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION CONCENTRATE

INTRAVENOUS

Medical Information

L01XX19

xl 01 xx 19

Manufacturer Information

PHARM-D SINGAPORE PRIVATE LIMITED

TTY Biopharm Company Limited

Active Ingredients

Irinotecan hydrochloride trihydrate

20 mg/ml

Irinotecan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

IRINO Solution for I.V Infusion 20mg/ml - HSA Approval | MedPath